Tuesday, March 31, 2026

πŸ’Š Drug Discovery & Development in Dermatology – GCAD 2026

The Global Clinical & Aesthetic Dermatology Conference, scheduled for October 26–28, 2026 in Boston and Online, features a key session on Drug Discovery and Development in Dermatology.

This session highlights how innovative therapies move from laboratory research to real-world clinical applications in dermatology.

πŸ”¬ Key Highlights

• Translational research and target discovery
• Clinical trial design (Phase I–III)
• Biomarkers and digital health tools
• Regulatory frameworks (FDA/EMA)
• Drug safety and post-marketing studies
• Small molecules, biologics, and combination therapies
• Industry, biotech, and academic collaborations

πŸ“’ Share Your Research

Present your work in this advanced field:
πŸ“ Abstract Submission: https://globaldermatologyconference.com/abstract-submission

🎟 Register Now: https://globaldermatologyconference.com/register

πŸ“© Contact: dermatology@mathewsconference.com

Be part of advancing dermatology therapeutics and shaping the future of patient care.

#GCAD2026 #DrugDevelopment #Dermatology #ClinicalResearch #PharmaceuticalScience #BiotechInnovation #SkinResearch #MedicalConference #Healthcare #TranslationalMedicine #DermatologyExperts #GlobalConference 

No comments:

Post a Comment

GCAD-2026 – Call for Abstracts Abstract Submission Guidelines – GCAD 2026 The Global Clinical & Aesthetic Dermatology Conference (GCAD...